Register here or login:
Needs Assessment
Prior to 2000 all individuals with kidney damage were classified simply as having kidney disease or chronic renal insufficiency. At that time the National Kidney Foundation Outcomes Quality Initiative (K/DOQI) Advisory Board approved development of clinical practice guidelines to define chronic kidney disease (CKD) and classify stages in the progression of that disease. The goal was to provide a common language for communication among providers, patients, and others. It would also provide a framework to affect care and improve outcomes of CKD by identifying susceptibility, progression factors, and better define worsening kidney damage.
Data from NHANES III (1988-1994) indicated that 7.6 million adults over age 20 had a moderate decrease in glomerular filtration rate (GFR), now known as stage 3 CKD. Alarmingly in that same time period, only 400,000 were identified with severe decrease in GFR, now known as stage 4 CKD. Two outcomes were quickly recognized:
- Cardiovascular disease events are more common than kidney failure in patients with CKD and it is treatable.
- The level of kidney function tends to decline progressively over time in most patients with CKD.
The result of the K/DOQI Advisory Board actions after reviewing extensive evidence was the development of the Clinical Practice Guidelines for Chronic Kidney Disease released in February 2002. These guidelines are the basis for both current and future interventional guidelines.
"Kidneys for Life: Diabetes, Hypertension, and More: Managing the Patient with Chronic Kidney Disease" introduces and provides specific information related to the current cardiovascular and kidney disease implications in the early stages (1 ? 3) of CKD based on those K/DOQI guidelines.
Learning Objectives
At the conclusion of the scheduled program, participants should be able to:
- Have knowledge of the prevalence of CKD
- Understand which patient populations are at risk for CKD
- Understand the importance of early intervention.
- Identify and screen patients at risk for chronic kidney disease (CKD)
- Appropriately treat CKD with diabetes, hypertension, and/or dyslipidemia
- Understand stage 3 CKD treatment considerations
- Have knowledge of anemia in CKD
- Have knowledge of parathyroid hormone and bone disease management in CKD
Receive Free CME Credit
To receive your free 1 credit hour:
- Listen to the presentation below
- Complete the online "CME" Post Test.
Successful completion of the self-assessment is required to earn CME credit. Successful completion is defined as a cumulative score of at least 70% correct. You may print your CME certificate on-line after successful completion.
Lectures
Accreditation Statement
Physicians
Educational Review Systems (ERS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the Essential areas and policies of the Accreditation Council for Continuing Medical Education.
Educational Review Systems designates this educational activity for a maximum of (1) AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Md#07-021
Nurses
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 5-115-07-042
Educational Review Systems is also approved for nursing continuing education by the state of California and the District of Columbia.
Faculty Financial Disclosure Statements
As a continuing medical education provider accredited by the ACCME, it is the policy of Educational Review Systems, Inc. to require any individual in a position to influence educational content to disclose the existence of any financial interest or other personal relationship with the manufacturer(s) of any commercial product(s).
The presenting faculty reported the following:
Dr. Mutinga has no commercial support disclosures that are relevent.